Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Beth Israel Deaconess Medical Center.
Recruitment status was  Active, not recruiting
Information provided by:
Beth Israel Deaconess Medical Center Identifier:
First received: September 13, 2005
Last updated: May 26, 2010
Last verified: May 2010

September 13, 2005
May 26, 2010
Not Provided
Not Provided
Global improvement in IBS symptoms
Same as current
Complete list of historical versions of study NCT00179582 on Archive Site
  • Frequency of bowel movements
  • Changes in abdominal pain
  • Changes in bloating
Same as current
Not Provided
Not Provided
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS
The study will evaluate 2 doses of VSL#3 and placebo over a 4 week period in patients presenting with diarrhea predominant IBS symptoms.
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Drug: VSL#3
Not Provided
Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study. Clin Nutr. 2005 Dec;24(6):925-31. Epub 2005 Jul 27.

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Active, not recruiting
Not Provided
Not Provided

Inclusion Criteria:

  • IBS diarrhea

Exclusion Criteria:

  • < 18 years of age
  • Pregnancy/breast feeding
  • concomitant medications to reduce bowel function
18 Years and older
Contact information is only displayed when the study is recruiting subjects
United States
2004P-000001, VSL1
Not Provided
Not Provided
Beth Israel Deaconess Medical Center
Not Provided
Principal Investigator: Anthony Lembo, MD Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
May 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP